Alpine Woods Capital Investors, LLC Biogen Inc. Transaction History

Alpine Woods Capital Investors, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 06, 2019	SELL	$216.71 - $338.96 $151,697 - $237,272	-700 Closed	0 $0
Q4 2018 Feb 13, 2019	SELL	$278.5 - $352.75 $835 - $1,058	-3 Reduced 0.43%	700 $211,000
Q3 2018 Nov 08, 2018	BUY	$293.51 - $383.83 $206,337 - $269,832	703 New	703 $248,000

1,037

126M

1.13M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.6B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Alpine Woods Capital Investors, LLC, based on Form 13F filings with the SEC.

Stay updated on Alpine Woods Capital Investors, LLC with notifications on news.